InsiderClue
Insiders · Profile

Tananbaum James B.

Director at Latigo Biotherapeutics · Director at ALUMIS. Filing since 1 Jul 2024. CIK 0001581754

LTGO Latigo Biotherapeutics, Inc. Director · 1 trade ALMS ALUMIS INC. Director · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
LTGO Latigo Biotherapeutics, Inc.
10 Aug 2026
Director
Bought
140,000
$2.52M
7.5%
ALMS ALUMIS INC.
8 Jan 2026
Director
Bought
411,764
$7.00M
7.8%
ALMS ALUMIS INC.
21 Nov 2025
Director
Bought
72,212
$532.92K
2.8%
ALMS ALUMIS INC.
19 Nov 2025
Director
Bought
190,500
$1.25M
8.1%
ALMS ALUMIS INC.
18 Nov 2025
Director
Bought
117,374
$726.55K
5.3%
ALMS ALUMIS INC.
17 Nov 2025
Director
Bought
200,000
$1.12M
9.8%
ALMS ALUMIS INC.
6 May 2025
Director
Bought
20,000
$86.80K
0.5%
ALMS ALUMIS INC.
2 May 2025
Director
Bought
25,000
$115.50K
0.6%
ALMS ALUMIS INC.
1 Jul 2024
Director
Bought
2,500,000
$40.00M
81.0%
9 decisions on file.